McManus Matthew 4
4 · BIO-TECHNE Corp · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
Bio-Techne (TECH) President Matthew McManus Receives Vesting RSUs
What Happened
Matthew McManus, President — Diagnostic & Spatial Bio at Bio‑Techne (TECH), had 4,621 restricted stock units (RSUs) vest and convert into shares on 2026-02-01. The RSU conversion is recorded at $0 (no cash purchase). To cover tax withholding, 1,665 of the vested shares were surrendered at an indicated price of $64.09 per share, a withholding value of $106,710. Net shares delivered to McManus after withholding: 2,956 shares.
This was an award vesting event (not an open‑market sale or purchase); share withholding for taxes is a routine settlement rather than a discretionary sale.
Key Details
- Transaction date: 2026-02-01; Form 4 filed 2026-02-03 (timely).
- Converted/received: 4,621 RSUs → 4,621 shares (code M, conversion of derivative) at $0.00.
- Tax withholding: 1,665 shares disposed (code F) at $64.09 each, total $106,710.
- Net shares retained by insider after withholding: 2,956 shares.
- Relevant footnote(s): F1 = each RSU equals one share; F3 = 4,621 RSUs vest on 2/1/2026 (vesting schedule).
- Transaction codes: M = exercise/conversion of derivative (RSU settlement); F = payment of tax liability via share withholding.
Context
- This is a vesting/settlement event for RSUs — common compensation practice. The withholding of shares to cover taxes is effectively a cashless settlement and does not indicate an open‑market sale.
- No purchase was made (not a bullish buy signal) and no discretionary sale occurred; information is primarily useful to see executive compensation being realized.
- Filing appears timely (filed within two business days).
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-01+4,621→ 9,356 total - Tax Payment
Common Stock
2026-02-01$64.09/sh−1,665$106,710→ 7,691 total - Exercise/Conversion
Restricted Stock Units
[F1][F3]2026-02-01−4,621→ 4,620 total→ Common Stock (4,621 underlying)
- 2,888
Performance Restricted Stock Units
[F1][F2]→ Common Stock (2,888 underlying) - 7,951
Performance Stock Option (Right to Buy)
[F2]Exercise: $68.54Exp: 2031-02-01→ Common Stock (7,951 underlying) - 15,902
Stock Option (Right to Buy)
[F4]Exercise: $68.54Exp: 2031-02-01→ Common Stock (15,902 underlying) - 15,825
Performance Restricted Stock Units
[F1][F5]→ Common Stock (15,825 underlying) - 5,275
Restricted Stock Units
[F1][F6]→ Common Stock (5,275 underlying) - 21,320
Stock Option (Right to Buy)
[F7]Exercise: $74.91Exp: 2034-08-15→ Common Stock (21,320 underlying) - 19,243
Performance Restricted Stock Units
[F1][F8]→ Common Stock (19,243 underlying) - 9,622
Restricted Stock Units
[F1][F9]→ Common Stock (9,622 underlying) - 24,614
Stock Option (Right to Buy)
[F10]Exercise: $53.60Exp: 2035-08-15→ Common Stock (24,614 underlying)
Footnotes (10)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F10]Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028.
- [F2]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F3]4,621 restricted stock units vest on 2/1/2026 and 4,620 restricted stock units vest on 2/1/2027.
- [F4]Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
- [F5]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F6]2,637 restricted stock units vest on 8/15/2026 and 2,638 restricted stock units vest on 8/15/2027.
- [F7]Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- [F8]Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F9]3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028.